Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18268
Country/Region: Haiti
Year: 2016
Main Partner: Catholic Medical Mission Board
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $5,500,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $536,496
Care: TB/HIV (HVTB) $273,377
Care: Pediatric Care and Support (PDCS) $359,806
Strategic Information (HVSI) $55,879
Health Systems Strengthening (OHSS) $50,000
Testing: HIV Testing and Counseling (HVCT) $706,446
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $366,518
Treatment: Adult Treatment (HTXS) $2,840,390
Treatment: Pediatric Treatment (PDTX) $311,088
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 41
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 5
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 41
GEND_GBV Number of people receiving post-GBV care 2017 46
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 13,014
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 13,014
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 60,187
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 43,582
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 129,797
HTS_TST Service Delivery Point (Facility): Inpatient 2017 964
HTS_TST Service Delivery Point (Facility): Pediatric 2017 26,030
HTS_TST Service Delivery Point (Facility): PMTCT 2017 25,796
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 2,551
HTS_TST Service Delivery Point (Facility): VCT 2017 74,458
HTS_TST Sum of Aggregated Age/Sex <15 2017 26,028
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 103,769
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 129,797
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 125
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 125
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,556
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,124
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that perform this testing 2017 12
PMTCT_ART Already on ART at beginning of current pregnancy 2017 206
PMTCT_ART New on ART 2017 308
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 25,796
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 276
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 227
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 8
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 10
PMTCT_EID Sum of Infant Age disaggregates 2017 503
PMTCT_STAT By: Known positives at entry 2017 251
PMTCT_STAT By: Number of new positives identified 2017 289
PMTCT_STAT Number of new ANC and L&D clients 2017 27,271
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 25,796
PMTCT_STAT Sum of Positives Status disaggregates 2017 540
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 30
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 262
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 19
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 176
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 487
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 487
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 229
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 71
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 229
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 34
TB_SCREENDX Screen Result: Screened Positive for TB 2017 229
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 5,858
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 3,901
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 557
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 373
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 10,689
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 184
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,347
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 122
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 898
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 2,551
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 2,700
TX_CURR Aggregated Age/Sex: <15 Female 2017 557
TX_CURR Aggregated Age/Sex: <15 Male 2017 373
TX_CURR Aggregated Age/Sex: 15+ Female 2017 5,858
TX_CURR Aggregated Age/Sex: 15+ Male 2017 3,901
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 10,689
TX_CURR Sum of Aggregated Age/Sex <15 2017 930
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 9,759
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 10,689
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 143
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 143
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,495
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 1,079
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 2,860
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 2,860
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 10,689
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 8,019
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 419
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 278
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 4,391
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 2,931
TX_PVLS Numerator: Indication: Routine 2017 7,217
TX_PVLS Numerator: Indication: Targeted 2017 802
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 557
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 373
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 5,858
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 3,901
TX_PVLS_den Denominator: Indication: Routine 2017 9,623
TX_PVLS_den Denominator: Indication: Targeted 2017 1,066
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 41
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 29
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 831
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 482
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 1,383
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,807
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 54
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 37
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,086
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 630
Cross Cutting Budget Categories and Known Amounts Total: $3,355,000
Motor Vehicles: Purchased $35,000
Food and Nutrition: Commodities $20,000
Human Resources for Health $3,300,000